Literature DB >> 2398270

Arsenic and non-cirrhotic portal hypertension. A report of eight cases.

F Nevens1, J Fevery, W Van Steenbergen, R Sciot, V Desmet, J De Groote.   

Abstract

It was discovered that eight patients with complications of non-cirrhotic portal hypertension had received an arsenical preparation for psoriasis as Fowler's solution some years age. Seven of them were admitted for bleeding oesophageal varices. Upon admission, splenomegaly and hypersplenism were present. Liver tests were normal and palmar skin keratosis and melanosis were noted. Liver biopsy of six patients showed features of incomplete septal cirrhosis. Malignant skin lesions were present in half of the patients. One patient died from lung carcinoma and another from an ovarium neoplasm. Chronic arsenic intake should be actively looked for in all patients with psoriasis and non-cirrhotic portal hypertension. They should be followed up for many years for development of malignant lesions in skin, lung and liver. Liver abnormalities present in the biopsies are often minor and may escape detection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398270     DOI: 10.1016/0168-8278(90)90276-w

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  14 in total

1.  Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors.

Authors:  C E Eapen; Peter Nightingale; Stefan G Hubscher; Peter J Lane; Timothy Plant; Dimitris Velissaris; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2010-05-25       Impact factor: 3.199

2.  Estimation of Trace Elements, Antioxidants, and Antibacterial Agents of Regularly Consumed Indian Medicinal Plants.

Authors:  Subhasmita Swain; Tapash R Rautray
Journal:  Biol Trace Elem Res       Date:  2020-06-11       Impact factor: 3.738

3.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

4.  Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice.

Authors:  Subhadip Ghatak; Ayan Biswas; Gopal Krishna Dhali; Abhijit Chowdhury; James L Boyer; Amal Santra
Journal:  Toxicol Appl Pharmacol       Date:  2010-12-04       Impact factor: 4.219

5.  Patient with hepatocellular carcinoma related to prior acute arsenic intoxication and occult HBV: epidemiological, clinical and therapeutic results after 14 years of follow-up.

Authors:  Teresa Casanovas-Taltavull; Josepa Ribes; Ana Berrozpe; Sara Jordan; Aurora Casanova; Concha Sancho; Carles Valls; F Xavier Bosch
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

6.  Hepatorenal Toxicity of Inorganic Arsenic in White Pekin Ducks and Its Amelioration by Using Ginger.

Authors:  Santosh Kumar Panda; Dhirendra Kumar; Geeta Rani Jena; Ramesh Chandra Patra; Susen Kumar Panda; Kamdev Sethy; Surya Kant Mishra; Bijaya Kumar Swain; Prafulla Kumar Naik; Chandra Kant Beura; Bhagyalaxmi Panda
Journal:  Biol Trace Elem Res       Date:  2022-06-20       Impact factor: 3.738

Review 7.  Liver is a target of arsenic carcinogenesis.

Authors:  Jie Liu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2008-06-19       Impact factor: 4.849

8.  Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis.

Authors:  Ashish Goel; Banumathi Ramakrishna; Jayaprakash Muliyil; Kadiyala Madhu; K G Sajith; Uday Zachariah; Jeyamani Ramachandran; Shyamkumar N Keshava; R Selvakumar; George M Chandy; Elwyn Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

9.  Arsenicosis, possibly from contaminated groundwater, associated with noncirrhotic intrahepatic portal hypertension.

Authors:  Ashish Goel; Pamela Christudoss; Renu George; Banumathi Ramakrishna; G Jayakumar Amirtharaj; Shyamkumar N Keshava; Anup Ramachandran; K A Balasubramanian; Ian Mackie; Jude J Fleming; Elwyn Elias; Chundamannil E Eapen
Journal:  Indian J Gastroenterol       Date:  2016-05-26

10.  Arsenic decreases RXRα-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes.

Authors:  Trisha L Noreault-Conti; Abigail Fellows; Judith M Jacobs; Heidi W Trask; Stephen C Strom; Ronald M Evans; Steven A Wrighton; Peter R Sinclair; Jacqueline F Sinclair; Ralph C Nichols
Journal:  Int Immunopharmacol       Date:  2012-02-04       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.